Insider Buy/Sell Details for the Healthcare Sector — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1111)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$556.48
Total Value
$222.59K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
930
Price
$555.77
Total Value
$516.87K
Shares Held After
324,843
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$554.51
Total Value
$268.94K
Shares Held After
325,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
185
Price
$553.70
Total Value
$102.43K
Shares Held After
326,258
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$552.29
Total Value
$243.01K
Shares Held After
326,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
486
Price
$551.09
Total Value
$267.83K
Shares Held After
326,883
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
874
Price
$550.14
Total Value
$480.82K
Shares Held After
327,369
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,173
Price
$549.13
Total Value
$644.13K
Shares Held After
328,243
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
387
Price
$548.18
Total Value
$212.14K
Shares Held After
329,416
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
629
Price
$546.94
Total Value
$344.03K
Shares Held After
329,803
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
493
Price
$545.85
Total Value
$269.10K
Shares Held After
330,432
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,098
Price
$544.82
Total Value
$1.14M
Shares Held After
330,925
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
744
Price
$543.76
Total Value
$404.56K
Shares Held After
333,023
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
176
Price
$542.73
Total Value
$95.52K
Shares Held After
333,767
% of Holdings
0.1%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$18.10
Total Value
$872.40K
Shares Held After
471,301
% of Holdings
9.3%
RESMED INC (RMD)
Farrell Michael J. — Director
Shares
4,991
Price
$226.33
Total Value
$1.13M
Shares Held After
479,803
% of Holdings
1.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,147
Price
$30.66
Total Value
$35.17K
Shares Held After
452,245
% of Holdings
0.3%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
2,006
Price
$4.63
Total Value
$9.29K
Shares Held After
2,792,690
% of Holdings
0.1%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
24,000
Price
$95.86
Total Value
$2.30M
Shares Held After
63,209
% of Holdings
27.5%
Emergent BioSolutions Inc. (EBS)
DeGolyer Donald W — Director
Shares
17,800
Price
$7.09
Total Value
$126.20K
Shares Held After
111,921
% of Holdings
13.7%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
1,301
Price
$8.32
Total Value
$10.82K
Shares Held After
137,170
% of Holdings
0.9%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
917
Price
$8.32
Total Value
$7.63K
Shares Held After
126,854
% of Holdings
0.7%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
3,221
Price
$8.32
Total Value
$26.80K
Shares Held After
340,038
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,780
Price
$110.81
Total Value
$197.25K
Shares Held After
767,780
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,920
Price
$109.89
Total Value
$1.09M
Shares Held After
769,560
% of Holdings
1.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,000
Price
$109.33
Total Value
$656.00K
Shares Held After
779,480
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,300
Price
$107.90
Total Value
$248.17K
Shares Held After
785,480
% of Holdings
0.3%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
272,695
Price
$7.18
Total Value
$1.96M
Shares Held After
6,358,271
% of Holdings
4.3%
IDEAYA Biosciences, Inc. (IDYA)
Hata Yujiro S — Director
Shares
800
Price
$38.26
Total Value
$30.61K
Shares Held After
690,695
% of Holdings
0.1%
IDEAYA Biosciences, Inc. (IDYA)
Hata Yujiro S — Director
Shares
25,538
Price
$37.39
Total Value
$954.79K
Shares Held After
691,495
% of Holdings
3.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
499
Price
$30.53
Total Value
$15.23K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
901
Price
$29.71
Total Value
$26.77K
Shares Held After
378,301
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
1,100
Price
$28.21
Total Value
$31.03K
Shares Held After
379,202
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
9,381
Price
$27.36
Total Value
$256.66K
Shares Held After
380,302
% of Holdings
2.4%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
6,444
Price
$30.00
Total Value
$193.32K
Shares Held After
389,350
% of Holdings
1.6%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,601
Price
$1.33
Total Value
$7.44K
Shares Held After
940,622
% of Holdings
0.6%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
1,990
Price
$60.04
Total Value
$119.48K
Shares Held After
94,784
% of Holdings
2.1%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
35,790
Price
$10.02
Total Value
$358.62K
Shares Held After
7,311,930
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
206
Price
$19.26
Total Value
$3.97K
Shares Held After
105,134
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,511
Price
$18.58
Total Value
$325.35K
Shares Held After
105,340
% of Holdings
14.3%
908 Devices Inc. (MASS)
Griffith Joseph H. IV — Chief Financial Officer
Shares
5,000
Price
$13.03
Total Value
$65.15K
Shares Held After
116,497
% of Holdings
4.1%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
3,375
Price
$32.03
Total Value
$108.11K
Shares Held After
453,392
% of Holdings
0.7%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Gibson James R II — Chief Financial Officer
Shares
661,815
Price
$3.11
Total Value
$2.06M
Shares Held After
1,083,848
% of Holdings
37.9%
Hinge Health, Inc. (HNGE)
Perez Daniel Antonio — Director
Shares
4,100
Price
$100.20
Total Value
$410.81K
Shares Held After
0
% of Holdings
100.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
HERSHBERG ROBERT — Director
Shares
25,000
Price
$5.00
Total Value
$125.00K
Shares Held After
162,156
% of Holdings
13.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
50,000
Price
$4.84
Total Value
$242.00K
Shares Held After
6,108,287
% of Holdings
0.8%
Jazz Pharmaceuticals plc (JAZZ)
GALA RENEE D — Director
Shares
2,000
Price
$236.40
Total Value
$472.80K
Shares Held After
141,394
% of Holdings
1.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
435
Price
$64.16
Total Value
$27.91K
Shares Held After
105,272
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$545.50
Total Value
$43.64K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
842
Price
$544.75
Total Value
$458.68K
Shares Held After
324,523
% of Holdings
0.3%
1111 transactions